FDA advisers vote in support of Paxlovid approval for Covid-19 treatment in high-risk adults

FDA advisers vote in support of Paxlovid approval for Covid-19 treatment in high-risk adults | CNN FDA advisers voted 16-1 on Thursday in support of approval of Paxlovid, stating that the benefits outweigh the risks of the drug for treatment of mild-to-moderate Covid-19 in adult high risk for progression to severe disease, including hospitalization and death. Janelle Chavez CNN

..

“I’d say besides oxygen, Paxlovid has probably been the single most important tool in this epidemic, and it continues to be,” said Dr. Richard Murphy, chief of infectious diseases with the Veterans Affairs White River Junction Medical Center and a member of the FDA’s Antimicrobial Drugs Advisory Committee, who voted in support of approval at the meeting.

...